Thank you for
joining us at #ASCO2023

Spotlight on rivoceranib

Learn how the mechanism of action of rivoceranib helps define its clinical potential.

View our data shared during the 2023 ASCO^® Annual Meeting

Phase 1, Randomized, Open-label, Single-dose, Crossover Study to Evaluate the Bioequivalence of Four Formulations of Oral Rivoceranib Tablets in Healthy Subjects

Updated Results from a Phase 2 Study of the Oral Vascular Endothelial Growth Factor Receptor 2 (VEGFR2) Inhibitor, Rivoceranib, for Recurrent or Metastatic (R/M) Adenoid Cystic Carcinoma (ACC)

Experience the #ElevarBigPicture

Portraits of Caring

Take a selfie to support charity and be a part of our Big Picture Experience

Immersive Experience

See the relative selectivity of TKIs through our interactive touchscreen display

See the photo mosaic come together in real time

Watch our Big Picture Experience come to life. Elevar Therapeutics will donate to a charity that supports patients with liver cancer on behalf of all those who participated.

Stay connected

Sign up to receive important information about rivoceranib, company news and updates, or to connect with a member of our team.

Look for us at future events

ESMO World GI Congress, Booth 105b
June 28-July 1, 2023 in Barcelona, Spain

ESMO Congress
October 22-24, 2023 in Madrid, Spain

Cookie	Duration	Description
cookielawinfo-checkbox-advertisement	1 year	Set by the GDPR Cookie Consent plugin, this cookie is used to record the user consent for the cookies in the "Advertisement" category .
cookielawinfo-checkbox-analytics	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
cookielawinfo-checkbox-functional	11 months	The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
cookielawinfo-checkbox-necessary	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-others	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.
cookielawinfo-checkbox-performance	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".
CookieLawInfoConsent	1 year	Records the default button state of the corresponding category & the status of CCPA. It works only in coordination with the primary cookie.
JSESSIONID	session	The JSESSIONID cookie is used by New Relic to store a session identifier so that New Relic can monitor session counts for an application.
viewed_cookie_policy	11 months	The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.

Cookie	Duration	Description
_ga	2 years	The _ga cookie, installed by Google Analytics, calculates visitor, session and campaign data and also keeps track of site usage for the site's analytics report. The cookie stores information anonymously and assigns a randomly generated number to recognize unique visitors.
_ga_J9N59KKZLK	2 years	This cookie is installed by Google Analytics.

Thank you forjoining us at #ASCO2023